Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,932
datasets available to search
ShareScore release 0.9.0
Dataset results
1,932 results for “Metformin”
GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
ClinicalTrials.gov study NCT00707031. IPD Sharing: Not stated. Countries: 18. Publications: 2.
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin
ClinicalTrials.gov study NCT01519674. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Treating Nonalcoholic Steatohepatitis (NASH) With Metformin
ClinicalTrials.gov study NCT00063232. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02128932. IPD Sharing: Not stated. Countries: 15. Publications: 12.
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes
ClinicalTrials.gov study NCT00859898. IPD Sharing: Not stated. Countries: 6. Publications: 1.
RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects
ClinicalTrials.gov study NCT02980276. IPD Sharing: NO. Countries: 1. Publications: 3.
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
ClinicalTrials.gov study NCT01517373. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
ClinicalTrials.gov study NCT00082407. IPD Sharing: Not stated. Countries: 12. Publications: 3.
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
ClinicalTrials.gov study NCT02500147. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Safety of Continuing Metformin in Diabetic Patients With Normal Kidney Function Receiving Contrast Media
ClinicalTrials.gov study NCT01873859. IPD Sharing: Not stated. Countries: 1. Publications: 1.
GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
ClinicalTrials.gov study NCT00712673. IPD Sharing: Not stated. Countries: 16. Publications: 4.
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01167881. IPD Sharing: Not stated. Countries: 23. Publications: 5.
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabe
ClinicalTrials.gov study NCT00960661. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD
ClinicalTrials.gov study NCT04220021. IPD Sharing: NO. Countries: 1. Publications: 6.
Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
ClinicalTrials.gov study NCT02104804. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
ClinicalTrials.gov study NCT02515773. IPD Sharing: NO. Countries: 1. Publications: 3.
Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT00611884. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01917656. IPD Sharing: Not stated. Countries: 7. Publications: 2.
The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)
ClinicalTrials.gov study NCT01106625. IPD Sharing: Not stated. Countries: 12. Publications: 17.
Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00286442. IPD Sharing: Not stated. Countries: 17. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.